The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
NebuClear MD
racepinephrine hydrochloride · RACEPINEPHRINE HYDROCHLORIDE 11.25 mg/.5mL · Solution · Respiratory (Inhalation) · Blue Echo Care LLC
NDC 73117-0523-19 · 40 mL in 1 BOX · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M012
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of racepinephrine hydrochloride (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Nephron Pharmaceuticals Corporation | RACEPINEPHRINE HYDROCHLORIDE 11.25 mg/.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Blue Echo Care LLC | RACEPINEPHRINE HYDROCHLORIDE 11.25 mg/.5mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "NebuClear MD — NDC 73117-0523-19," retrieved September 3, 2026, https://drugdashboards.com/drug/73117052319.
Free to cite with attribution — see how the data is put together.